top of page
Pipeline
Radella Pharmaceuticals
Radella Pharmaceuticals is dedicated to creating groundbreaking drugs that address the root causes of severe diseases with high unmet medical need.
VISION
Robust Pipeline Funded Through POC Studies
Validating human data expected late-2024
Radella's novel MOA unlocks potential in additional high-value indications.
We continue to explore longer duration formulations, non-subcutaneous routes of administration, and small molecule approaches – as well as the potential synergies of our therapy when used in combination with incretins.
bottom of page